This supports previous observations in a cohort of 108 patients with breast cancer, in which higher intratumoral protein levels of GSDMD correlated with lower pathological grade, smaller tumor size and lower TNM classification stage (34). This evidence concerns the gene GSDMD and breast carcinoma.